Cell Line

HUVEC-GFP, GFP-expressing Human Umbilical Vein Endothelial Cells

Organism

Human

Tissue/Cell type

Human umbilical vein

Genetically modified (GenTSV)

S1

Risk group (BioStoffV)

1

Risk assessment

According to Formblatt Z, Gentechnische Abeit Nr. 7, Anlage 92/14, see data sheets below and here

Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)

sourcefreezing datepassage no.cell count per vialcell culture medium incl. supplementsno. of aliquotsbelongs to
(full name)
rack/box in N2 tank or -80°° freezer and  location (room, address)

comments










Cellworks11.02.202031 Mio

Vasculife® Lifefactors® VEGF medium

0


Laura Elomaa10/1, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1)








Cellworks22.07.202141 Mio

Vasculife® Lifefactors® VEGF medium

0


Laura Elomaa14/5, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1)








cellworks27.10.202140.5mioVasculife® Lifefactors® VEGF medium1Wanjun Liang7/1, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1)








cellworks1.11.202141 MioVasculife® Lifefactors® VEGF medium0Laura Elomaa10/1, N2 tank, (SupraFab, Altensteinstraße 23a, 114.1)








Background

Contains GFP-HUVECs from multiple donors. The cells stably express CMV-driven TagGFP2, which has an excitation peak of 483nm and an emission peak of 506nm. 

Cultivation and freezing protocols






Data sheets, further information